187 related articles for article (PubMed ID: 26993605)
1. Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay.
Jia K; Li W; Wang F; Qu H; Qiao Y; Zhou L; Sun Y; Ma Q; Zhao X
Oncotarget; 2016 Apr; 7(17):23569-80. PubMed ID: 26993605
[TBL] [Abstract][Full Text] [Related]
2. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Liu LH; Shan BE; Tian ZQ; Sang MX; Ai J; Zhang ZF; Meng J; Zhu H; Wang SJ
Clin Chem Lab Med; 2010 Jun; 48(6):855-61. PubMed ID: 20345231
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.
Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S
Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
Xu YW; Peng YH; Ran LQ; Zhai TT; Guo HP; Qiu SQ; Chen HL; Wu ZY; Li EM; Xie JJ
Clin Transl Oncol; 2017 Jul; 19(7):898-906. PubMed ID: 28181176
[TBL] [Abstract][Full Text] [Related]
5. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
[TBL] [Abstract][Full Text] [Related]
6. Tubulin beta chain, filamin A alpha isoform 1, and cytochrome b-c1 complex subunit 1 as serological diagnostic biomarkers of esophageal squamous cell carcinoma: a proteomics study.
Fan NJ; Gao CF; Wang XL
OMICS; 2013 Apr; 17(4):215-23. PubMed ID: 23496306
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma.
Gao SG; Yang JQ; Ma ZK; Yuan X; Zhao C; Wang GC; Wei H; Feng XS; Qi YJ
BMC Cancer; 2018 Jan; 18(1):17. PubMed ID: 29298684
[TBL] [Abstract][Full Text] [Related]
8. The association between serum Dickkopf-1 levels and esophageal squamous cell carcinoma.
Begenik H; Kemik AS; Emre H; Dulger AC; Demirkiran D; Ebinc S; Kemik O
Hum Exp Toxicol; 2014 Aug; 33(8):785-8. PubMed ID: 24220876
[TBL] [Abstract][Full Text] [Related]
9. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
[TBL] [Abstract][Full Text] [Related]
10. Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling.
Okano T; Seike M; Kuribayashi H; Soeno C; Ishii T; Kida K; Gemma A
Int J Oncol; 2016 Mar; 48(3):945-52. PubMed ID: 26783151
[TBL] [Abstract][Full Text] [Related]
11. [Serum proteomic spectra of esophageal squamous cell carcinoma patients analyzed with IMAC3 protein chip].
Liu CZ; Zhu PY; Shi MX; Liu JB; Liao P; Xiang CQ; Zhang YX; Wang WJ
Ai Zheng; 2008 Mar; 27(3):272-8. PubMed ID: 18334116
[TBL] [Abstract][Full Text] [Related]
12. Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma.
Xu YW; Liu CT; Huang XY; Huang LS; Luo YH; Hong CQ; Guo HP; Xu LY; Peng YH; Li EM
Dis Markers; 2017; 2017():5384091. PubMed ID: 28852266
[TBL] [Abstract][Full Text] [Related]
13. Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches.
Zhang LY; Ying WT; Mao YS; He HZ; Liu Y; Wang HX; Liu F; Wang K; Zhang DC; Wang Y; Wu M; Qian XH; Zhao XH
World J Gastroenterol; 2003 Apr; 9(4):650-4. PubMed ID: 12679903
[TBL] [Abstract][Full Text] [Related]
14. Utility of serum peptidome patterns of esophageal squamous cell carcinoma patients for comprehensive treatment.
Wan QL; Hou XS; Zhao G
Asian Pac J Cancer Prev; 2013; 14(5):2919-23. PubMed ID: 23803054
[TBL] [Abstract][Full Text] [Related]
15. Comparative serum proteomic analysis of serum diagnosis proteins of colorectal cancer based on magnetic bead separation and maldi-tof mass spectrometry.
Deng BG; Yao JH; Liu QY; Feng XJ; Liu D; Zhao L; Tu B; Yang F
Asian Pac J Cancer Prev; 2013; 14(10):6069-75. PubMed ID: 24289627
[TBL] [Abstract][Full Text] [Related]
16. Identification of extracellular matrix protein 1 as a potential plasma biomarker of ESCC by proteomic analysis using iTRAQ and 2D-LC-MS/MS.
Wang X; Peng Y; Xie M; Gao Z; Yin L; Pu Y; Liu R
Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28493612
[TBL] [Abstract][Full Text] [Related]
17. Combining proteomics, serum biomarkers and bioinformatics to discriminate between esophageal squamous cell carcinoma and pre-cancerous lesion.
Zhai XH; Yu JK; Lin C; Wang LD; Zheng S
J Zhejiang Univ Sci B; 2012 Dec; 13(12):964-71. PubMed ID: 23225851
[TBL] [Abstract][Full Text] [Related]
18. Serum peptidome patterns for early screening of esophageal squamous cell carcinoma.
Fan NJ; Gao CF; Zhao G; Wang XL; Qiao L
Biotechnol Appl Biochem; 2012; 59(4):276-82. PubMed ID: 23586861
[TBL] [Abstract][Full Text] [Related]
19. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
[TBL] [Abstract][Full Text] [Related]
20. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis.
Yang YF; Li H; Xu XQ; Diao YT; Fang XQ; Wang Y; Zhao DL; Wu K; Li HQ
Dis Esophagus; 2008; 21(5):395-401. PubMed ID: 19125792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]